Subscribe To
HROW / Harrow (HROW) is on the Move, Here's Why the Trend Could be Sustainable
HROW News
By Seeking Alpha
September 27, 2023
Harrow Health's 5-Year Guidance
Harrow Health has guided to at least $1 billion in revenue by 2027 based on their current portfolio of drugs. The company's deep moat and strong custo more_horizontal
By Seeking Alpha
August 9, 2023
Harrow Health, Inc. (HROW) Q2 2023 Earnings Call Transcript
Harrow Health, Inc. (NASDAQ:HROW ) Q2 2023 Earnings Conference Call August 9, 2023 4:45 PM ET Company Participants Jamie Webb - Director-Communication more_horizontal
By Seeking Alpha
August 1, 2023
Harrow Health And Its Interesting 11.6% 2027 Baby Bond
Harrow Health is an eye care pharmaceuticals company. The common stock has been on fire with expectations of rapidly increasing profits. HROW has 2 ba more_horizontal
By Zacks Investment Research
July 20, 2023
Strength Seen in Harrow (HROW): Can Its 17.8% Jump Turn into More Strength?
Harrow (HROW) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the st more_horizontal
By The Motley Fool
July 19, 2023
Why Shares of Harrow Health Are Jumping Wednesday
Harrow added seven new products through an acquisition. The company said it expects increased revenue year over year in the second quarter. more_horizontal
By Zacks Investment Research
June 23, 2023
Harrow Health (HROW) Flat As Market Sinks: What You Should Know
Harrow Health (HROW) closed at $18.52 in the latest trading session, marking no change from the prior day. more_horizontal
By Seeking Alpha
June 12, 2023
Harrow Health: Mostly Good, Some Bad
Harrow Healthcare is well-positioned to grow in the US Ophthalmology market, with a branded pharma sales strategy that could boost growth and margins. more_horizontal
By The Motley Fool
May 12, 2023
Why Shares of Harrow Health Are Slumping Friday
Harrow had a $6.6 million loss in the first quarter. It just launched its latest therapy, the ocular anesthesia Iheeza. more_horizontal